Exercise + Psychological Support for ACL Reconstruction Rehabilitation
(ACLR-REPS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to examine ACLR Rehabilitation with Exercise and Psychological Support (REPS), comparing two approaches for providing psychological support along with exercise during ACL reconstruction rehabilitation. In one group, physical therapists have received training that may boost emotional support during rehabilitation. In the other group, physical therapists will not have the training. Both groups will get similar exercises and participate in the same testing. Both groups will also watch short videos during rehabilitation that are specific to their group. Participants will not know to which group they are assigned until the end of the study. Participation will attend a total of four study visits over the course of 6 months, including 1 visit before the surgery and 3 visits during follow-up.
Are You a Good Fit for This Trial?
This trial is for young athletes aged 15-21 who had ACL surgery within the last 6 months and plan to return to sports that involve cutting, jumping, or pivoting. They must have been active in sports before injury and aim to resume at a similar level. Rehabilitation will take place at TRIA Gameface.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-surgery Baseline
Participants attend a baseline visit before surgery to assess initial conditions
Treatment
Participants undergo ACL reconstruction and receive rehabilitation with exercise and psychological support
Follow-up
Participants are monitored for psychological readiness and knee function post-treatment
What Are the Treatments Tested in This Trial?
Interventions
- Rehabilitation with Exercise and Psychological Support (REPS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
HealthPartners Institute
Lead Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborator